Ignacio Garrido-Laguna

8PUBLICATIONS
89CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 22, 2026
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated Melanoma.

|May 09, 2024
Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of Pancreatic Carcinomas: In Search of Therapeutic Targets.

Erik B Faber, Harris B Krause, Khalid Amin

|Aug 03, 2023
Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration.

Gregory L Beatty, Devora Delman, Jiayi Yu

|Jun 02, 2023
Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC.

Vaia Florou, Andrew Elliott, Matthew H Bailey

|Mar 27, 2023
A Preclinical and Phase Ib Study of Palbociclib plus Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas.

Manuel Hidalgo, Rocio Garcia-Carbonero, Kian-Huat Lim

|Mar 13, 2023
Multianalyte Serum Biomarker Panel for Early Detection of Pancreatic Adenocarcinoma.

Matthew A Firpo, Kenneth M Boucher, Josh Bleicher

Pageof 2

Frequent Collaborators

2 joint publications

Peter J Hosein

2 joint publications

Emil Lou

2 joint publications

Vaia Florou

2 joint publications

Kajsa E Affolter